News &
Events

 

Latest News

Drug candidate may recover vocal abilities lost to ADNP syndrome

Protein snippet normalizes disrupted neural connectivity caused by genetic disorder, Tel Aviv University researchers say

Read More

A JOINT RESEARCH COLLABORATION WITH A GLOBAL PHARMA COMPANY ON PROTEIN DEGRADATION PLATFORM

TEL AVIV, ISRAEL, October 8th, Tel Aviv University (TAU) through Ramot, its Business Engagement Center, announce the signing of a collaboration agreement with Novartis to explore several applications and uses of a novel platform for identified new targets and modulators of the ubiquitin pathways developed by Prof. Gali Prag from the TAU School of Neurobiology Biochemistry and Biophysics.

Read More

Bsense Bio Therapeutics - a new spin-off

Bsense Bio Therapeutics is our new spin-off for the treatment of neuropathic pain.

Read More

May 2018 - Ramot Newsletter

Satisfaction survey results, call for proposals, new videos and startups updates...

Read More